Advertisement
Videos
Advertisement

Opinion: How ObamaCare Inflates the Cost of Cancer Treatment

Thu, 08/01/2013 - 9:22am

American Enterprise Institute resident fellow Scott Gottleib on the 340B program, how it inflates drug costs, and commonsense solutions

 


Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading